추가 설명:
Seysara is the only FDA-approved narrow-spectrum oral antibiotic for treating facial and truncal acne, showing visible improvement within 3 weeks and a 50% reduction in inflammatory lesions by week 12, with limited impact on beneficial gut bacteria and a low tendency toward antibiotic resistance, photosensitivity, GI effects, and vestibular effects.
평가 & 댓글 남기기